Filing Details

Accession Number:
0001567619-22-021284
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-05 17:00:29
Reporting Period:
2022-12-01
Accepted Time:
2022-12-05 17:00:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740719 V Kathy Turner One Idexx Drive
Westbrook ME 04092
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-01 3,000 $141.60 9,923 No 4 M Direct
Common Stock Disposition 2022-12-01 3,000 $436.00 6,923 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2022-12-01 3,000 $0.00 3,000 $141.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,386 2027-02-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100 Indirect by spouse
Footnotes
  1. The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
  2. Grant of option to buy 10,386 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2018.
  3. Not applicable.